NCT01866943View on ClinicalTrials.gov

Role of Topical Tranexamic Acid in Total Hip Arthroplasty

PHASE2TerminatedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Post Operative Blood Loss
Interventions
DRUG

Tranexamic Acid

Tranexamic Acid 1.5 g (100 mg/mL)in 100cc normal saline is applied topically to the wound for 5 minutes time then suctioned and the skin closed. The control group receives just normal saline and no drug.

DRUG

Normal Saline Solution

Trial Locations (1)

10075

North Shore Long Island Jewish Lenox Hill Hospital, New York

Sponsors

Lead Sponsor

Northwell Health
All Listed Sponsors
lead

Northwell Health

OTHER